(Q40941304)

25 September 2017

Intracellular and cell surface displayed single-chain diabodies (English)

1 reference

25 September 2017

Kontermann RE

1

1 reference

PubMed ID

10410983

25 September 2017

Müller R

series ordinal

2

1 reference

25 September 2017

1 June 1999

1 reference

Journal of Immunological Methods

25 September 2017

1 reference

25 September 2017

226

1 reference

25 September 2017

1-2

1 reference

25 September 2017

179-188

1 reference

Intracellular immunization: antibody targeting to subcellular compartments

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Intracellular immunization with cytosolic recombinant antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

"Diabodies": small bivalent and bispecific antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Retargeting serum immunoglobulin with bispecific diabodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Mix and match: building manifold binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Oxidized redox state of glutathione in the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Tissue-specific, cell cycle-regulated chimeric transcription factors for the targeting of gene expression to tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Sequence requirements for nuclear location of simian virus 40 large-T antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Bispecific CD3 x CD19 diabody for T cell-mediated lysis of malignant human B cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Engineered turns of a recombinant antibody improve its in vivo folding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Complement recruitment using bispecific diabodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Enzyme immunoassays using bispecific diabodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Specific targeting of cytokine-secreting cells: a bispecific diabody recognizing human interleukin-6 and CD3 induces T cell-mediated killing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Expression of an antibody fragment at high levels in the bacterial cytoplasm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

A C-terminal signal prevents secretion of luminal ER proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

High-affinity antigen binding by chelating recombinant antibodies (CRAbs).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

A strategy for enhancing the transcriptional activity of weak cell type-specific promoters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Crystal structure of a diabody, a bivalent antibody fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

New protein engineering approaches to multivalent and bispecific antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Antibody scFv fragments without disulfide bonds made by molecular evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

High level secretion of a humanized bispecific diabody from Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2899%2900062-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-1759(99)00062-9

1 reference

25 September 2017

1 reference

PubMed ID

10410983